BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2021
View Archived Issues
Cancer vaccine CVD908ssb-TXSVN enters phase I study for multiple myeloma
Read More
Vidutolimod to be studied in triple-negative breast cancer and non-melanoma skin cancer
Read More
First patient dosed with CIT-013, a first-in-class antagonist targeting NETs
Read More
Complexes cross BBB, knock down CNS genes in rodents
Read More
Collaboration announced for phase II study of larazotide for COVID-19-derived MIS-C
Read More
Joint venture announcement behind AR-035 and AR-882 development in China
Read More
DNMT3a and DNA methylation alterations in the nucleus accumbens are involved in PTSD-like behavior
Read More
Sichuan Kelun-Biotech Biopharmaceutical patents TGFR1 inhibitors
Read More
Jiangsu Simcere Pharmaceutical presents BTK and JAK3 inhibitors
Read More
Enanta Pharmaceuticals synthesizes new antiviral compounds
Read More
Sirnaomics describes new siRNAs targeting SARS-CoV-2
Read More
Istari Oncology expands LUMINOS-103 trial of PVSRIPO to include HNSCC
Read More
Transcenta begins phase II trial of TST-001 in solid tumors
Read More
Phase I study of Alzheimer's disease candidate AL-001 to begin in September
Read More
Preclinical toxicology study supports development of antidiarrheal lechlemer
Read More
Ganaxolone reduces seizure frequency in tuberous sclerosis complex patients
Read More
HER2 expression is a prognostic factor in DCIS
Read More
Pirfenidone shows favorable effects in patients with HFpEF
Read More
ExeVir's COVID-19 treatment and prophylactic XVR-011 enters clinical study
Read More
